User:Aarz1111/sandbox

New Legislation

On October 9th, 2017 Governor Jerry Brown of California passed Senate Bill 17 (SB-17) Health care: prescription drug costs. 

This bill focuses on transparency regarding pharmaceutical companies. This bill mainly focuses on two aspects. The first being that drug companies

must give prior notice of price increases for prescription drugs. Drug Manufacturers must 

notify state purchasers such as CalPERS, Medi-Cal etc. 90 days prior to the planned effective date. The second focus is on 

the transparency of spending trends. This means that health plans and insurers have to annually report all covered drugs (categorized

by generic drugs, brand names, and specialty drugs)

• the 25 most prescribed drugs
• the 25 most costly drugs
• the 25 drugs with the highest year-over-year increase in total annual spending. ^[1]

This information will help the public and policy makers see spending trends on medication and be able to shift focus on how best to

utilize the healthcare dollar.